FR177391, A New Anti-hyperlipidemic Agent from Serratia
Open Access
- 1 October 2005
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 58 (10) , 654-662
- https://doi.org/10.1038/ja.2005.90
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- FR177391, A New Anti-hyperlipidemic Agent from SerratiaThe Journal of Antibiotics, 2005
- FR177391, A New Anti-hyperlipidemic Agent from SerratiaThe Journal of Antibiotics, 2005
- Thiazolidinediones in Type 2 Diabetes MellitusDrugs, 2003
- Regulation of PPARγ transcriptional activity in 3T3-L1 adipocytesBiochemical and Biophysical Research Communications, 2003
- 9th International Conference on Obesity, NIDDM, Adipogenesis and Insulin ResistanceExpert Opinion on Investigational Drugs, 2000
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994
- Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by antagonists of adipogenesisMolecular and Cellular Biochemistry, 1993
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990